• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

NCCN Guidelines for Early-Stage Breast Cancer: Abemaciclib and Ribociclib

Opinion
Video

William J. Gradishar, MD, highlights the inclusion of abemaciclib in the NCCN Guidelines for select high-risk early-stage breast cancer patients, anticipates the potential for ribociclib to secure a similar guideline position, and emphasizes the importance of monitoring treatment response.

  1. Abemaciclib has been integrated into the NCCN Guidelines for certain patients with high-risk early-stage disease. What data is needed for ribociclib to find a similar position in the guidelines?
  2. What are the guideline recommendations for monitoring for response to systemic treatment in breast cancer? What outcomes are most important when monitoring response to treatment?
Related Videos
Antonio Urbina, MD
4 Experts are featured in this series
4 Experts are featured in this series
2 experts in this video
2 experts in this video
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Related Content
BRCA1/2 gene test | Image Credit: luchschenF - stock.adobe.com

Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups

December 4th 2025
Article

Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

ACIP Delays the HepB vaccine schedule as safety debates and policy tensions escalate. | Image Credit: @didesign-AdobeStock.jpeg

ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy

December 4th 2025
Article

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

Read More

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

November 11th 2025
Podcast

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

New insights on the effectiveness of guideline-recommended HF therapies in Chagas disease. | Image credit: appledesign - stock.adobe.com

Heart Failure Therapies Show Limited Impact in Chagas Disease

December 3rd 2025
Article

Guideline-recommended HF therapies do not improve major outcomes in Chagas disease, though sacubitril/valsartan improved NT-proBNP levels, new data show.

Read More

Dry eye | Image credit: Kryuchka Yaroslav - stock.adobe.com

Maintaining Tear Film Stability in Dry Eye Requires Frequent Blinking

December 3rd 2025
Article

New research shows that those with dry eye need more than 20 blinks per minute to maintain their tear film.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.